Guinea-Bissau is suspending a Trump administration-backed hepatitis B vaccine study on newborns in the West African country, pending an ethical review, the health minister said Thursday.
A six-person ethics committee didn't meet to review the study during the initial confirmation process, Health Minister Quinhi Nantot said during a news conference held by the Africa Centers for Disease Control and Prevention.
